{"entity":{"type":"insider","cik":"0001612357","url":"/insider/0001612357","json_url":"/insider/0001612357.json","name":"Gennadios Aristippos","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":22,"n_filings":14,"first":"2015-04-03","last":"2024-08-05","span_basis":"filed_date"},"name_variants":[{"name":"Gennadios Aristippos","source":"filing","n_filings":14,"first_seen":"2015-04-03","last_seen":"2024-08-05"}],"transactions":[{"id":2511329,"accession":"0001596783-24-000066","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001596783-24-000066","line_url":"/filing/0001596783-24-000066#line-1","is_derivative":false,"issuer_cik":"0001596783","issuer_name":"Catalent, Inc.","issuer_ticker":"CTLT","issuer_name_source":null,"issuer_url":"/issuer/0001596783","owner_cik":"0001612357","owner_name":"Gennadios Aristippos","owner_display_name":"Gennadios Aristippos","owner_url":"/insider/0001612357","role":"Officer (Group Pres. Pharma & Consumer)","role_mark":"O","role_mark_label":"Officer (Group Pres. Pharma & Consumer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Group Pres. Pharma & Consumer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1169.0,"shares_display":"1,169","price_per_share":59.55,"price_display":"59.55","price_state":"stated","total_value":69613.95,"total_display":"69,613.95","total_whole":"69,614","shares_owned_after":113724.0,"shares_owned_after_display":"113,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-02","filed_date":"2024-08-05","scope":"insider"},{"id":2114828,"accession":"0001596783-24-000045","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001596783-24-000045","line_url":"/filing/0001596783-24-000045#line-2","is_derivative":false,"issuer_cik":"0001596783","issuer_name":"Catalent, Inc.","issuer_ticker":"CTLT","issuer_name_source":null,"issuer_url":"/issuer/0001596783","owner_cik":"0001612357","owner_name":"Gennadios Aristippos","owner_display_name":"Gennadios Aristippos","owner_url":"/insider/0001612357","role":"Officer (Group Pres. Pharma & Consumer)","role_mark":"O","role_mark_label":"Officer (Group Pres. Pharma & Consumer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Group Pres. Pharma & Consumer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":349.0,"shares_display":"349","price_per_share":58.7,"price_display":"58.70","price_state":"stated","total_value":20486.3,"total_display":"20,486.30","total_whole":"20,486","shares_owned_after":114893.0,"shares_owned_after_display":"114,893","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-29","filed_date":"2024-07-30","scope":"insider"},{"id":8689622,"accession":"0001596783-23-000098","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001596783-23-000098","line_url":"/filing/0001596783-23-000098#line-2","is_derivative":false,"issuer_cik":"0001596783","issuer_name":"Catalent, Inc.","issuer_ticker":"CTLT","issuer_name_source":null,"issuer_url":"/issuer/0001596783","owner_cik":"0001612357","owner_name":"Gennadios Aristippos","owner_display_name":"Gennadios Aristippos","owner_url":"/insider/0001612357","role":"Officer (Group Pres. Pharma & Consumer)","role_mark":"O","role_mark_label":"Officer (Group Pres. Pharma & Consumer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Group Pres. Pharma & Consumer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":396.0,"shares_display":"396","price_per_share":44.49,"price_display":"44.49","price_state":"stated","total_value":17618.04,"total_display":"17,618.04","total_whole":"17,618","shares_owned_after":96552.0,"shares_owned_after_display":"96,552","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-24","filed_date":"2023-08-25","scope":"insider"},{"id":7935099,"accession":"0001596783-23-000054","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001596783-23-000054","line_url":"/filing/0001596783-23-000054","is_derivative":false,"issuer_cik":"0001596783","issuer_name":"Catalent, Inc.","issuer_ticker":"CTLT","issuer_name_source":null,"issuer_url":"/issuer/0001596783","owner_cik":"0001612357","owner_name":"Gennadios Aristippos","owner_display_name":"Gennadios Aristippos","owner_url":"/insider/0001612357","role":"Officer (Group Pres. Pharma & Consumer)","role_mark":"O","role_mark_label":"Officer (Group Pres. Pharma & Consumer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Group Pres. Pharma & Consumer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":281.0,"shares_display":"281","price_per_share":47.58996441281139,"price_display":"47.59","price_state":"stated","total_value":13372.78,"total_display":"13,372.78","total_whole":"13,373","shares_owned_after":86488.0,"shares_owned_after_display":"86,488","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-01","filed_date":"2023-08-03","scope":"insider","n_lines":2},{"id":6434954,"accession":"0001596783-22-000115","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001596783-22-000115","line_url":"/filing/0001596783-22-000115#line-2","is_derivative":false,"issuer_cik":"0001596783","issuer_name":"Catalent, Inc.","issuer_ticker":"CTLT","issuer_name_source":null,"issuer_url":"/issuer/0001596783","owner_cik":"0001612357","owner_name":"Gennadios Aristippos","owner_display_name":"Gennadios Aristippos","owner_url":"/insider/0001612357","role":"Officer (Group Pres. Pharma & Consumer)","role_mark":"O","role_mark_label":"Officer (Group Pres. Pharma & Consumer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Group Pres. Pharma & Consumer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1645.0,"shares_display":"1,645","price_per_share":103.04,"price_display":"103.04","price_state":"stated","total_value":169500.8,"total_display":"169,500.80","total_whole":"169,501","shares_owned_after":86769.0,"shares_owned_after_display":"86,769","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-25","filed_date":"2022-08-26","scope":"insider"},{"id":6356854,"accession":"0001596783-22-000067","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001596783-22-000067","line_url":"/filing/0001596783-22-000067#line-2","is_derivative":false,"issuer_cik":"0001596783","issuer_name":"Catalent, Inc.","issuer_ticker":"CTLT","issuer_name_source":null,"issuer_url":"/issuer/0001596783","owner_cik":"0001612357","owner_name":"Gennadios Aristippos","owner_display_name":"Gennadios Aristippos","owner_url":"/insider/0001612357","role":"Officer (Group Pres. Pharma & Consumer)","role_mark":"O","role_mark_label":"Officer (Group Pres. Pharma & Consumer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Group Pres. Pharma & Consumer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":403.0,"shares_display":"403","price_per_share":106.9,"price_display":"106.90","price_state":"stated","total_value":43080.7,"total_display":"43,080.70","total_whole":"43,081","shares_owned_after":79784.0,"shares_owned_after_display":"79,784","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-26","filed_date":"2022-07-28","scope":"insider"},{"id":4833090,"accession":"0001596783-21-000125","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001596783-21-000125","line_url":"/filing/0001596783-21-000125","is_derivative":false,"issuer_cik":"0001596783","issuer_name":"Catalent, Inc.","issuer_ticker":"CTLT","issuer_name_source":null,"issuer_url":"/issuer/0001596783","owner_cik":"0001612357","owner_name":"Gennadios Aristippos","owner_display_name":"Gennadios Aristippos","owner_url":"/insider/0001612357","role":"Officer (President Softgel & Oral Tech)","role_mark":"O","role_mark_label":"Officer (President Softgel & Oral Tech)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President Softgel & Oral Tech","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2262.0,"shares_display":"2,262","price_per_share":131.13120689655173,"price_display":"131.13","price_state":"stated","total_value":296618.79,"total_display":"296,618.79","total_whole":"296,619","shares_owned_after":57481.0,"shares_owned_after_display":"57,481","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-27","filed_date":"2021-08-30","scope":"insider","n_lines":2},{"id":4193670,"accession":"0001596783-21-000093","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001596783-21-000093","line_url":"/filing/0001596783-21-000093#line-2","is_derivative":false,"issuer_cik":"0001596783","issuer_name":"Catalent, Inc.","issuer_ticker":"CTLT","issuer_name_source":null,"issuer_url":"/issuer/0001596783","owner_cik":"0001612357","owner_name":"Gennadios Aristippos","owner_display_name":"Gennadios Aristippos","owner_url":"/insider/0001612357","role":"Officer (President Softgel & Oral Tech)","role_mark":"O","role_mark_label":"Officer (President Softgel & Oral Tech)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President Softgel & Oral Tech","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":465.0,"shares_display":"465","price_per_share":113.05,"price_display":"113.05","price_state":"stated","total_value":52568.25,"total_display":"52,568.25","total_whole":"52,568","shares_owned_after":50850.0,"shares_owned_after_display":"50,850","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-26","filed_date":"2021-07-28","scope":"insider"},{"id":5078207,"accession":"0001596783-21-000015","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001596783-21-000015","line_url":"/filing/0001596783-21-000015#line-1","is_derivative":false,"issuer_cik":"0001596783","issuer_name":"Catalent, Inc.","issuer_ticker":"CTLT","issuer_name_source":null,"issuer_url":"/issuer/0001596783","owner_cik":"0001612357","owner_name":"Gennadios Aristippos","owner_display_name":"Gennadios Aristippos","owner_url":"/insider/0001612357","role":"Officer (President Softgel & Oral Tech)","role_mark":"O","role_mark_label":"Officer (President Softgel & Oral Tech)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President Softgel & Oral Tech","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":110.0,"shares_display":"110","price_per_share":104.42,"price_display":"104.42","price_state":"stated","total_value":11486.2,"total_display":"11,486.20","total_whole":"11,486","shares_owned_after":51315.0,"shares_owned_after_display":"51,315","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-05","scope":"insider"},{"id":2188157,"accession":"0001596783-20-000230","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001596783-20-000230","line_url":"/filing/0001596783-20-000230","is_derivative":false,"issuer_cik":"0001596783","issuer_name":"Catalent, Inc.","issuer_ticker":"CTLT","issuer_name_source":null,"issuer_url":"/issuer/0001596783","owner_cik":"0001612357","owner_name":"Gennadios Aristippos","owner_display_name":"Gennadios Aristippos","owner_url":"/insider/0001612357","role":"Officer (President Softgel & Oral Tech)","role_mark":"O","role_mark_label":"Officer (President Softgel & Oral Tech)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President Softgel & Oral Tech","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13662.0,"shares_display":"13,662","price_per_share":102.84321475625823,"price_display":"102.84","price_state":"stated","total_value":1405044.0,"total_display":"1,405,044.00","total_whole":"1,405,044","shares_owned_after":51425.0,"shares_owned_after_display":"51,425","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-21","filed_date":"2020-12-23","scope":"insider","n_lines":2},{"id":2716501,"accession":"0001596783-20-000060","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001596783-20-000060","line_url":"/filing/0001596783-20-000060#line-5","is_derivative":false,"issuer_cik":"0001596783","issuer_name":"Catalent, Inc.","issuer_ticker":"CTLT","issuer_name_source":null,"issuer_url":"/issuer/0001596783","owner_cik":"0001612357","owner_name":"Gennadios Aristippos","owner_display_name":"Gennadios Aristippos","owner_url":"/insider/0001612357","role":"Officer (President Softgel & Oral Tech)","role_mark":"O","role_mark_label":"Officer (President Softgel & Oral Tech)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President Softgel & Oral Tech","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8325.0,"shares_display":"8,325","price_per_share":73.0,"price_display":"73.00","price_state":"stated","total_value":607725.0,"total_display":"607,725.00","total_whole":"607,725","shares_owned_after":44520.0,"shares_owned_after_display":"44,520","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-25","filed_date":"2020-06-29","scope":"insider"},{"id":8749554,"accession":"0001596783-19-000214","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001596783-19-000214","line_url":"/filing/0001596783-19-000214#line-13","is_derivative":false,"issuer_cik":"0001596783","issuer_name":"Catalent, Inc.","issuer_ticker":"CTLT","issuer_name_source":null,"issuer_url":"/issuer/0001596783","owner_cik":"0001612357","owner_name":"Gennadios Aristippos","owner_display_name":"Gennadios Aristippos","owner_url":"/insider/0001612357","role":"Officer (President Softgel & Oral Tech)","role_mark":"O","role_mark_label":"Officer (President Softgel & Oral Tech)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President Softgel & Oral Tech","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45256.0,"shares_display":"45,256","price_per_share":52.55,"price_display":"52.55","price_state":"stated","total_value":2378202.8,"total_display":"2,378,202.80","total_whole":"2,378,203","shares_owned_after":44241.0,"shares_owned_after_display":"44,241","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-25","filed_date":"2019-11-27","scope":"insider"},{"id":8536843,"accession":"0001596783-19-000025","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001596783-19-000025","line_url":"/filing/0001596783-19-000025","is_derivative":false,"issuer_cik":"0001596783","issuer_name":"Catalent, Inc.","issuer_ticker":"CTLT","issuer_name_source":null,"issuer_url":"/issuer/0001596783","owner_cik":"0001612357","owner_name":"Gennadios Aristippos","owner_display_name":"Gennadios Aristippos","owner_url":"/insider/0001612357","role":"Officer (President, Softgel Tech)","role_mark":"O","role_mark_label":"Officer (President, Softgel Tech)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Softgel Tech.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3392.0,"shares_display":"3,392","price_per_share":42.18439858490566,"price_display":"42.18","price_state":"stated","total_value":143089.48,"total_display":"143,089.48","total_whole":"143,089","shares_owned_after":34792.0,"shares_owned_after_display":"34,792","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-21","filed_date":"2019-03-25","scope":"insider","n_lines":2},{"id":8785528,"accession":"0001633970-15-000010","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001633970-15-000010","line_url":"/filing/0001633970-15-000010","is_derivative":false,"issuer_cik":"0001596783","issuer_name":"Catalent, Inc.","issuer_ticker":"CTLT","issuer_name_source":null,"issuer_url":"/issuer/0001596783","owner_cik":"0001612357","owner_name":"Gennadios Aristippos","owner_display_name":"Gennadios Aristippos","owner_url":"/insider/0001612357","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24868.0,"shares_display":"24,868","price_per_share":30.61,"price_display":"30.61","price_state":"stated","total_value":761209.48,"total_display":"761,209.48","total_whole":"761,209","shares_owned_after":8651.0,"shares_owned_after_display":"8,651","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-01","filed_date":"2015-04-03","scope":"insider","n_lines":5}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":22,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":22,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":22},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001596783","name":"Catalent, Inc.","url":"/issuer/0001596783","role":"Officer (Group Pres. Pharma & Consumer)","n_filings":14,"first_seen":"2015-04-03","last_seen":"2024-08-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001612357","retrieved_at":"2026-08-25T19:48:12+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}